SCH708980 With and Without AmBisome for Visceral Leishmaniasis

NCT01437020 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

NIH

Sponsor class

Stopped Drug Product no longer available.

Conditions

Leishmaniasis
Effects of Immunotherapy

Interventions

DRUG: SCH708980 Anti-IL-10 monoclonal
DRUG: AmBisome

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)